Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.23.1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 38,415,549 $ 25,155 $ 68,208,081   $ (29,817,687)
Beginning balance, Shares at Dec. 31, 2021   25,155,198      
Stock-based compensation expense 123,229   123,229    
Issuance of common stock for services 67,000 $ 50 66,950    
Issuance of common stock for services, Shares   50,000      
Issuance of common stock, stock options exercised 44,142 $ 22 44,120    
Issuance of common stock, stock options exercised, Shares   21,853      
Net loss (4,640,601)       (4,640,601)
Ending balance at Mar. 31, 2022 34,009,319 $ 25,227 68,442,380   (34,458,288)
Ending balance, Shares at Mar. 31, 2022   25,227,051      
Beginning balance at Dec. 31, 2022 $ 21,035,401 $ 25,227 68,777,298 $ 104,718 (47,871,842)
Beginning balance, Shares at Dec. 31, 2022 25,227,051 25,227,051      
Stock-based compensation expense $ 123,273   123,273    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 8,579,023 $ 5,829 8,573,194    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   5,829,187      
Other comprehensive income 61,104     61,104  
Net loss (4,477,778)       (4,477,778)
Ending balance at Mar. 31, 2023 $ 25,321,023 $ 31,056 $ 77,473,765 $ 165,822 $ (52,349,620)
Ending balance, Shares at Mar. 31, 2023 31,056,238 31,056,238